|
|
|
| Cancer survivors and cancer survivorship research in the United States |
| LU Weidong |
| Dana-Farber Cancer Institute, Harvard Medical School, Boston 02215, USA |
|
|
|
|
Abstract Cancer survivors are persons living with cancer. It has become a reality that a cancer patient can live for many years after a cancer diagnosis due to the advancement of medical treatment and newly developed cancer drugs. Nevertheless, during and after the completion of anti-cancer therapies, and during the later follow-ups and monitoring the cancer recurrence, cancer survivors face unique physical, psychological, economic and social challenges. These issues include managing long-term toxicities and later effects of anti-cancer therapies; the changes from a cancer patient to a cancer survivor; the transition from cancer treatments to healthy living and the readjustment of their roles in the society and their families. In addition, many oncologists and community family physicians are not familiar with the concept of cancer survivorship with inadequate professional training. In past 30 years, the research and services of cancer survivorship is becoming an emerging branch of medicine in the United States and Europe, which comprises multidisciplinary professionals, governments, social services, cancer patients and their families. We reviewed and analysised the definition, history, development and current research of cancer survivorship in the United States. Comparing with the current cancer condition in China, we provided directions and perspectives of cancer survivorship research and services for the cancer community in China.
|
|
|
|
|
|
| [1] |
WANG Chao-yun， DU Cheng， GUAN Xin， DU Xiao-wei， XU Zhu-xuan， ZHENG Zhen-dong. Advances in drug therapy for cancer cachexia[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 382-385. |
| [2] |
SHENG Xiang， LI Su-yi. Advances in research on intestinal microecology and clinical outcomes of tumors[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 178-182. |
| [3] |
1, 3YUAN Fei, 2, 3, 4WANG Shu-bin. Progress of ribosomal protein in malignant tumor therapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(1): 116-119. |
| [4] |
XIE Lin-ying, WANG Chang, WU Hai-tao, WANG Yi-zhuo, LIANG Ting-ting, HE Hua, YAO Cheng, LI Wei. The analysis and the investigation of malnutrition in 744 elderly inpatients with tumor[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(4): 380-386. |
| [5] |
1LI Tao, 1LV Jia-hua,1LANG Jin-yi, 2SHI Han-ping, 3XU Hong-xia, 4LI Bao-sheng, 5ZHANG Zhen, 6 ZHU Shu-chai, 7CHEN Ming, 8KANG Jing-bo, . Expert consensus on nutrition therapy in cancer patients receiving radiotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(4): 358-36. |
| [6] |
ZHANG Xiao-wei, CHENG Xue-jiao, LI Yao, WANG Kai, DONG Guan-nan. Observation on the effect of complex protein components on the nutritional status of patients with malignant tumors in digestive tract[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(4): 372-375. |
|
|
|
|
